Severe abortion pill complications 22 times higher than FDA discloses, study finds

More than one in 10 women may experience serious complications, such as hemorrhaging or severe infection, from medication abortions, according to a large-scale study published Monday.

The new study, published by the anti-abortion Ethics and Public Policy Center, examined insurance claims data from over 865,000 mifepristone prescriptions from 2017 to 2023 and found that nearly 11% of women experience a potentially life-threatening complication within 45 days of a mifepristone abortion.